Robaxin
NDC Package 0091-7429-63

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Robaxin is a medication used to treat muscle spasms/pain. Marketed by Ucb, Inc., this product is identified by NDC 0091-7429 and is authorized under FDA application NDA011011.

Identification & Billing

NDC Package Code
0091-7429-63
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
0091-7429
11-Digit Billing Format
00091742963

Clinical Specifications

Proprietary Name
Robaxin
Dosage Form
-
Usage Information
This medication is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It may work by causing drowsiness and helping to relax the muscles.

Regulatory & Marketing

Labeler Name
Ucb, Inc.
FDA Application #
NDA011011
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-15-2003
End Marketing Date
01-17-2013
Listing Expiration
01-17-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0091-7429-63 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Robaxin, labeled by Ucb, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ucb, Inc. on January 15, 2003. The current certification is valid through January 17, 2013.

What are the primary indications for this medication?

This medication is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It may work by causing drowsiness and helping to relax the muscles.

How is this Ucb, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00091742963. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0091-7429-63
11-Digit CMS (5-4-2)
00091-7429-63

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.